🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

CRIS CRIS

Company Profile ↓
$4.54
-85.80% 1Y
P/E-7.83
52W High$36.60
52W Low$4.20
EPS (TTM)$-0.58

Company Overview

CRIS (CRIS) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Dec 2025 Revenue of $9.44M (-13.4% YoY); net profit $-7.58M.
  • Trailing 12 Months Year-on-year growth — revenue -13.4%.
  • 5-Year Trend Long-term compounding — revenue CAGR 0.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:0.59%
1 Year:-13.43%

Stock Price Performance

1 Year:-85.80%
6 Months:-73.88%
3 Months:-60.13%
1 Month:-14.08%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 1% of range
$4.20 $36.60
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)38.94 · Neutral
Price Performance
1M-14.08%
3M-60.13%
6M-73.88%
1Y-85.80%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 87.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-7.83
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
0.59%
Profit 5Y
-
Revenue (YoY)
-13.43%
Earnings (YoY)
-

Profitability & Returns

ROCE
-96.99%
ROE
-138.81%
ROA
-37.97%
Profit Margin
-80.29%
Op Margin
-60.50%
Gross Margin
-
EPS (Latest Qtr)
$-25.00
EPS (TTM)
$-0.58

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$29.69M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
8.03%
Chg in Prom Hold
-
FII / Inst Holding
40.50%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$9.44M
EBITDA
-
Free Cash Flow
$-38.43M
Operating Cash Flow
$-27.20M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------2.13M2.06M2.44M3.26M2.47M2.36M2.85M2.75M1.77M2.09M2.86M3.29M2.71M2.36M2.74M3.02M2.19M2.29M3.04M2.06M2.39M2.83M2.30M2.20M2.83M2.09M2.55M2.93M2.38M2.75M3.18M1.14M0
Cost of Revenue -----------------------------------14.00K16.00K15.00K00
Gross Profit -----------------------------------2.37M2.73M3.16M1.14M0
Operating Expenses -----------------------------------12.52M10.98M10.09M8.71M11.52M
Operating Income -7.37M-4.84M-13.25M-8.81M-10.68M-27.79M-10.76M-15.05M-13.11M-14.47M-7.13M-9.91M-7.86M-6.42M-5.15M-5.56M-6.14M-5.32M-7.33M-8.48M-5.43M-4.71M-6.28M-8.80M-10.65M-10.05M-15.13M-15.06M-12.61M-11.63M-12.14M-12.37M-12.47M-12.51M-10.57M-10.16M-8.25M-6.92M-7.57M-11.52M
EBITDA ------------------------------------10.10M-8.21M-6.89M19.97M-11.51M
Interest Expense ----------------------------------------
Pretax Income ------------------------------------10.62M-8.59M-7.73M19.36M-24.20M
Tax Provision ----------------------------------------
Net Income -8.13M-5.54M-13.46M-9.44M-11.29M-28.34M-11.34M-15.74M-14.09M-15.46M-8.03M-10.75M-8.66M-7.22M-5.94M-9.88M-7.21M-6.44M-8.61M-9.71M-6.71M-5.97M-7.52M-9.93M-10.84M-11.05M-16.11M-15.94M-13.29M-11.56M-11.96M-12.18M-11.88M-11.80M-10.09M-10.62M-8.59M-7.73M19.36M-24.20M
Diluted EPS --------------------0.28-0.17-0.11--0.11-0.12-0.12-0.18-0.17-2.83-2.39-2.47-2.13-2.05-2.03-1.70-25.00-13.60-9.8024.60-25.00
R&D Expense 2.00M---------------------------------------

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 8.59M16.00M14.76M16.97M15.00M9.84M7.88M7.53M9.90M10.43M10.00M10.84M10.65M10.16M10.02M10.91M9.44M
Operating Income -10.04M-5.64M-7.20M-18.62M-9.42M-15.86M-56.48M-58.04M-49.76M-29.33M-24.36M-24.90M-42.06M-53.02M-48.33M-44.54M-5.71M
Net Income -9.82M-4.44M-9.86M-16.42M-12.32M-18.73M-58.98M-60.41M-53.32M-32.58M-32.14M-29.91M-45.44M-56.67M-47.41M-43.39M-7.58M
Diluted EPS -----------0.97-0.610.50-12.14-8.96-6.88-0.58
R&D Expense 9.93M11.37M13.69M15.49M12.93M13.66M-18.00M---------

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Sep 2010Dec 2010Sep 2011Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Apr 2020Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets ---50.65M-48.18M69.77M80.59M62.61M94.97M57.75M73.80M37.37M35.11M-204.36M162.30M108.85M77.28M41.27M19.97M
Total Equity 37.22M33.05M-45.52M-39.88M34.27M45.17M29.78M64.51M29.45M23.99M-4.50M-33.91M-130.67M90.71M46.55M19.67M-6.00M5.46M
Cash & Equivalents 10.16M7.28M7.83M7.83M15.12M15.12M12.75M9.59M7.75M33.09M26.04M38.29M23.64M15.43M-129.61M40.01M19.66M26.68M20.00M5.06M
Long Term Debt ------29.84M27.95M22.59M19.56M14.92M35.67M28.60M0900.00K------
Total Liabilities ---5.13M-8.30M35.50M35.42M32.83M30.45M28.49M49.80M41.86M69.02M-73.69M71.59M62.30M57.61M47.26M14.50M
Current Liabilities ---3.48M-3.79M3.98M6.56M10.07M10.76M13.55M14.10M13.25M6.54M-10.08M13.44M10.01M22.02M19.03M14.08M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -7.59M-1.63M-4.56M-15.19M-9.54M-16.81M-29.89M-35.81M-48.35M-30.07M-26.20M-25.74M-37.62M-54.34M-38.43M-39.56M-27.20M
Investing Cash Flow 818.34K-14.89M9.78M-23.00M-13.62M16.27M-6.43M30.12M-3.63M21.37M-4.46M-49.05M-47.90M33.02M37.79M29.44M2.50M
Financing Cash Flow 3.89M17.07M2.08M35.82M20.00M-1.30M61.66M-1.37M64.23M-5.96M23.27M188.81M-4.17M867.00K7.58M3.44M9.77M
Capital Expenditure -19.54K-274.84K-260.40K-104.97K-153.01K-92.00K-48.00K-329.00K-188.00K-85.00K-41.00K-677.00K-0-416.00K-0--
Free Cash Flow -7.61M-1.90M-4.82M-15.30M-9.69M-16.91M-29.94M-36.14M-48.54M-30.15M-26.25M-26.42M-37.62M-54.75M-38.43M--

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % -116.9%-35.2%-48.8%-109.7%-62.8%-161.2%-716.9%-771.1%-502.7%-281.3%-243.5%-229.8%-395.0%-521.7%-482.2%-408.3%-60.5%
Net Margin % -114.4%-27.7%-66.8%-96.7%-82.1%-190.3%-748.7%-802.6%-538.7%-312.4%-321.3%-276.0%-426.7%-557.7%-473.0%-397.8%-80.3%
ROE % -29.7%-9.7%-24.7%-47.9%-27.3%-62.9%-91.4%-205.1%-222.2%724.5%94.8%-22.9%-50.1%-121.7%-241.0%723.4%-138.8%
ROCE % --12.0%-16.2%-28.3%-12.7%-30.2%-67.1%-131.3%-83.4%-121.6%-85.3%-12.8%-28.3%-53.6%-87.5%-200.3%-97.0%

Shareholding Pattern

Insiders
8.03%
Institutions
40.50%
Public Float
44.04%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CRIS

Google News Wed, 22 Jul 2026

Curis (CRIS) Stock Sees Fair Value Lift As Analysts Back Leadership And Consumer Focus - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQM2U1UVJfM21iLUhTVk1CMXhUVllmMmdrZWVoZEtMUDM2ckhmNk9HdVU1YWoyTDRXd0w1UzI4VjNzclQ0OWpYZTkxcUdXUWtvc2xPeXUzZlRYQXZZWmw5SU1kSTJRNkFDbDJSMjdLRzFJcVM5UVRJdjUxM083ajQtVllxQ1hvMDBsWWxHaC…

Google News Wed, 05 Aug 2026

Bucharest stocks fall further, Cris-Tim leads blue-chip decliners - SeeNews

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNZnd0bjA1a2taWWZ2NkI1c3QwTUNIOVJFVW9vdnJFYmxRMFZ4bHZjVi1RS1ZMcHVvUkVWRkZVUG9vaUhPOTREMjlpYVZsR2hxWjJEOGVTekxJSEZXN3gtbHhqbzRJa2h1eFdSdm9OVWZuVkdrS0VURWpyWG9fUWpBUFhtUEFCandQUHViTD…

Google News Fri, 26 Jun 2026

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split - PR Newswire

<a href="https://news.google.com/rss/articles/CBMitgJBVV95cUxNY0tZTW93ckhFZE1iTFhKUnBIV0p4TWdpR2xtRG92YnJmSnUyOXJweFlKU1Y0V2dBQWhlTXJhZzIyRHhjYkZIWkQtaHBnMDFBVHlyalZkM3E3X2JXczRKOTdDM0JlNWdybXBRNkxNbzVZSmFnRHZKXzNMcnIxdmxmOUp4akJIWmgzNFBxVF…

Google News hu, 30 Jul 2026

Curis Pairs Emavusertib With Zanubrutinib in CLL Study - Stock Titan

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPY1UxMTVaTUVHTWw1UTR5QXBNaXYxTmRlUFlZQTA1QWZjVUpGdUZWZVJnTVVFbmlsNkwyNmtfS1FpLVRneC04NjVPR002T3dwSlQtenU0S3hTZVBtN2NGYzdyNHVzWFl0Q096Q2w5cHpJaTk1Zm1kOUo4OW1CeEYzYkpCMERSVVEyNkJ1SX…

Google News ue, 23 Jun 2026

Curis (CRIS) Stock Faces Mixed Analyst Target Changes Over Execution And Pipeline Risk - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNendwZEhBaS00eHRBSlNINWZrVWlWVVRJU3VTdXhKeldkTG1OQS0yTDVYNno2VzNNZFNtM0poMVBCOHNPcVh2Zm1rUlE5cF9udkl4a2M1eGdzcnNUd2RUaGlsQm5zNHBaT0c4TkFjckpzUGk2X25DVGRuR3NpSnpreDNPSWNBX21xY1ZMTF…

Google News Fri, 24 Jul 2026

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus - Benzinga

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNODRwWFJYbXBkclFUNTlLQXlPTWNHMmdMMTU1OWhpdDMzbTFJZWV6b2JhSFV4TjJxbGttVmZDQ3RURS1pcnNzMlQxbFk2V1Q0ZjZJeUI2UVdfOVZwQlJaQXllTWVVOF9EbVFpNHJrU2V0SE1yVTlxTXNndDNKTmZNQ0FrdzVsR0xvY0lRRy…

CRIS — Frequently Asked Questions

What is the current share price of CRIS?

As of 2026-08-05 17:25 PDT, CRIS trades at $4.54 on NASDAQ/NYSE. Its 52-week range is $4.20 to $36.60.

What is the P/E ratio of CRIS?

CRIS trades at a trailing price-to-earnings (P/E) ratio of -7.83.

What is the return on equity (ROE) of CRIS?

CRIS has a return on equity (ROE) of -138.81%. Its return on capital employed (ROCE) is -96.99%.

Is CRIS a good stock to buy?

This page provides a data-driven analysis of CRIS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space